When looking at before and after photos of neurotoxin treatments, the results from Botulax are often indistinguishable from those of more established brands like Botox or Dysport in the short term. The core mechanism—relaxing targeted muscles to smooth wrinkles—is identical because all these products are formulations of botulinum toxin type A. However, the differences emerge when you scrutinize the photos for finer details like onset of action, diffusion characteristics, and the subtle nuances of the final aesthetic effect. These variations are driven by the unique molecular properties and protein complex sizes of each product.
Understanding the Neurotoxin Landscape
To truly compare before and after photos, you first need to understand the players. The global neurotoxin market is dominated by a few key products, each with its own history and scientific profile. Botox (onabotulinumtoxinA) from AbbVie is the original and most widely recognized brand. Dysport (abobotulinumtoxinA) from Galderma is known for its potentially faster onset and wider spread. Xeomin (incobotulinumtoxinA) from Merz is a “naked” neurotoxin, free of complexing proteins. Botulax, manufactured by the South Korean company Hugel, is a prominent player in Asia and is gaining traction in other markets as a cost-effective alternative. While they all achieve the same fundamental goal, the devil is in the molecular details.
The Science Behind the Smoothed Forehead: Unit Potency and Conversion
One of the most critical factors affecting the outcome in photos is unit dosing, but it’s not as straightforward as a 1:1 swap. The units of measurement for Botox, Dysport, Xeomin, and Botulax are not directly equivalent due to differences in how they are manufactured and tested. This is where many practitioners note a key difference with Botulax.
Studies and clinical experience suggest that Botulax has a unit potency very similar to Botox. Many practitioners use a 1:1 conversion ratio when switching from Botox to Botulax. In contrast, Dysport is generally considered to have a lower potency per unit, with a commonly accepted conversion ratio of 1:2.5 or 1:3 ( meaning 2.5 to 3 units of Dysport are typically needed to achieve the effect of 1 unit of Botox). This dosing difference can influence the “spread” of the product, which is visibly apparent in before and after galleries.
The following table summarizes the typical conversion ratios based on clinical practice:
| Neurotoxin Brand | Typical Conversion Ratio (Compared to 1 Unit of Botox) | Key Characteristic |
|---|---|---|
| Botox (onabotulinumtoxinA) | 1:1 (Baseline) | Gold standard, predictable diffusion |
| Dysport (abobotulinumtoxinA) | 1:2.5 to 1:3 | Potential for faster onset, wider diffusion |
| Xeomin (incobotulinumtoxinA) | 1:1 | “Naked” toxin, potentially less risk of resistance |
| Botulax (letibotulinumtoxinA) | 1:1 | Similar profile to Botox, cost-effective |
When a practitioner uses the correct conversion, the final muscle relaxation and wrinkle-smoothing effect in photos should be very similar. However, an incorrect conversion is a primary reason for underwhelming or overly-diffused results seen in some comparison photos.
Analyzing the Timeline in Before and After Series
A series of photos taken over days and weeks reveals more than a single side-by-side image. The timeline of action—onset, peak effect, and duration—is where subtle differences between neurotoxins become apparent.
Onset of Action: How quickly do you see the first signs of smoothing? Patients receiving Dysport often report noticing effects a day or so earlier than with Botox, sometimes within 24-48 hours. Botox and Xeomin typically have a onset of 3-5 days. Clinical data on Botulax suggests an onset time comparable to Botox, with initial effects becoming visible around day 3-4 post-injection. In a before-and-after series, this means the “after” photo taken at day 2 might show more pronounced early effects with Dysport compared to Botulax.
Peak Effect: This is when the full result is evident. For all these toxins, the peak effect is usually reached between 10-14 days. A photo taken at the two-week mark is the truest representation of the product’s capability. At this stage, when administered by a skilled injector using proper dosing, it is exceedingly difficult to tell the difference between results from Botox, Xeomin, or Botulax based on the photo alone. The foreheads, glabellar lines (frown lines), and crow’s feet should all appear similarly smoothed.
Duration of Effect: This is a major point of discussion. The longevity of results can vary based on the individual’s metabolism, the dose used, and the treatment area. Generally, first-time users may experience a shorter duration, with effects lasting 3-4 months. With repeated treatments, the duration can extend. Anecdotal reports from practitioners suggest that Botulax may have a slightly shorter average duration than Botox—perhaps by a few weeks—especially in individuals with stronger facial muscles. This isn’t universally true, but it is a consideration when comparing long-term photo diaries where a patient might be due for a touch-up sooner with one product versus another.
Diffusion Profile: The Art of Precision
Perhaps the most significant factor visible in high-quality before and after photos is the diffusion profile—how the product spreads from the injection site. This is largely determined by the size of the protein complex surrounding the core neurotoxin molecule.
Dysport has a smaller protein complex size, which is believed to contribute to its wider area of diffusion. This can be a double-edged sword. It’s beneficial for treating broader areas like the forehead, where a more even spread is desired. However, it requires extreme caution around the eyes when treating crow’s feet, as wider diffusion could potentially affect muscles responsible for lower eyelid movement, leading to a droopy appearance (eyelid ptosis).
Botox and, by extension, Botulax, are described as having a more focused or predictable diffusion. The protein complex in Botulax is similar in size to that of Botox. This makes it an excellent choice for treatments requiring high precision, such as smoothing delicate horizontal lines on the bridge of the nose (bunny lines) or for creating a subtle lip flip without affecting the ability to smile normally. In before and after photos, you should see a very localized relaxation with Botulax, with the effect confined neatly to the intended treatment zone.
Xeomin, lacking complexing proteins altogether, is also theorized to have a very precise diffusion, though some studies suggest its spread may be slightly more limited than Botox’s.
Patient-Specific Factors That Influence the Photo Outcome
The product itself is only half of the equation. The patient’s unique biology and the injector’s skill are equally, if not more, important in determining what the “after” photo looks like.
Muscle Mass and Strength: An individual with very strong, hypertrophic corrugator muscles (the primary frown muscles) will require a higher dose of any neurotoxin to achieve a smooth result compared to someone with weaker muscles. A photo showing a dramatic transformation in a person with deep glabellar lines is a testament to both an adequate dose and a potent product.
Injector Technique and Experience: This cannot be overstated. An expert injector understands the intricate anatomy of the face, knows the precise depth and location for each injection, and tailors the dose and product choice to the patient’s goals and facial structure. A less experienced injector might place the toxin incorrectly, leading to asymmetrical results, a “frozen” or “Spock-like” eyebrow arch, or eyelid ptosis. When you see a perfect, natural-looking result in an after photo, it speaks volumes about the injector’s skill, regardless of whether Botox or Botulax was used.
Individual Metabolism: Some people simply metabolize botulinum toxin faster than others. These “fast metabolizers” will see the effects wear off more quickly, which would be evident in a timeline of photos showing a return to baseline expression lines sooner than the 3-4 month average.
Beyond the Forehead: A Look at Other Treatment Areas
While forehead and frown lines are the most common subjects of before and after photos, neurotoxins are used for a variety of other indications. The choice of product can be particularly relevant here.
For masseter reduction (slimming the jawline), which requires injecting a large, thick muscle, some practitioners prefer products with a wider diffusion like Dysport to cover the muscle more thoroughly. Others achieve excellent results with Botox or Botulax by using a higher dose and more injection points. The “after” photos should show a softer, more V-shaped jawline contour.
For hyperhidrosis (excessive sweating) of the underarms, palms, or feet, the diffusion characteristic is less of a concern for aesthetic outcomes, but efficacy is key. All approved toxins are highly effective, with studies showing >80% reduction in sweating. The before and after photos in this case are often supplemented with starch-iodine tests that visually demonstrate the dramatic reduction in sweat production.
In the delicate peri-oral area for a lip flip or to soften smoker’s lines, the precision of Botox or Botulax is often preferred to avoid affecting muscles necessary for speech and eating. The ideal after photo shows a subtly enhanced upper lip without a compromised smile.
Ultimately, the visual evidence presented in before and after photos confirms that Botulax is a potent and effective neurotoxin capable of producing results that are visually congruent with those of its more well-known competitors. The differences are subtle and often related to logistical factors like onset and duration rather than the ultimate quality of the wrinkle smoothing. The most crucial element for a successful outcome, clearly visible in a stellar after photo, remains the expertise of the healthcare professional holding the syringe.